Archives of Pharmacal Research

, Volume 37, Issue 12, pp 1607–1616

The osmotic stress response of split influenza vaccine particles in an acidic environment

Research Article

Abstract

Oral influenza vaccine provides an efficient means of preventing seasonal and pandemic disease. In this work, the stability of envelope-type split influenza vaccine particles in acidic environments has been investigated. Owing to the fact that hyper-osmotic stress can significantly affect lipid assembly of vaccine, osmotic stress-induced morphological change of split vaccine particles, in conjunction with structural change of antigenic proteins, was investigated by the use of stopped-flow light scattering (SFLS), intrinsic fluorescence, transmission electron microscopy (TEM), and hemagglutination assay. Split vaccine particles were found to exhibit a step-wise morphological change in response to osmotic stress due to double-layered wall structure. The presence of hyper-osmotic stress in acidic medium (0.3 osmolarity, pH 2.0) induced a significant level of membrane perturbation as measured by SFLS and TEM, imposing more damage to antigenic proteins on vaccine envelope than can be caused by pH-induced conformational change at acidic iso-osmotic condition. Further supports were provided by the intrinsic fluorescence and hemagglutinin activity measurements. Thus, hyper-osmotic stress becomes an important factor for determining stability of split vaccine particles in acidic medium. These results are useful in better understanding the destabilizing mechanism of split influenza vaccine particles in gastric environment and in designing oral influenza vaccine formulations.

Keywords

Influenza vaccine Split vaccine particle Whole inactivated virus vaccine particle Osmotic stress Stopped-flow light scattering 

Supplementary material

12272_2013_257_MOESM1_ESM.pdf (93 kb)
Supplementary material 1 (PDF 93 kb)

References

  1. Azizi, A., A. Kumar, F. Diaz-Mitoma, and J. Mestecky. 2010. Enhancing oral vaccine potency by targeting intestinal M cells. PLoS Pathogens 6: e1001147.PubMedCentralPubMedCrossRefGoogle Scholar
  2. Bullough, P.A., F.M. Hughson, J.J. Skehel, and D.C. Wiley. 1994. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 371: 37–43.PubMedCrossRefGoogle Scholar
  3. Choi, H.J., B.J. Bondy, D.G. Yoo, R.W. Compans, S.M. Kang, and M.R. Prausnitz. 2013a. Stability of whole inactivated influenza virus vaccine during coating onto metal microneedles. Journal of Controlled Release 166: 159–171.PubMedCentralPubMedCrossRefGoogle Scholar
  4. Choi, H.J., C.F. Ebersbacher, M.C. Kim, S.M. Kang, and C.D. Montemagno. 2013b. A mechanistic study on the destabilization of whole inactivated influenza virus vaccine in gastric environment. PLoS ONE 8: e66316.PubMedCentralPubMedCrossRefGoogle Scholar
  5. Choi, H.J., C.F. Ebersbacher, N.V. Myung, and C.D. Montemagno. 2012a. Synthesis of nanoparticles with frog foam nest proteins. Journal of Nanoparticle Research 14: 1–13.Google Scholar
  6. Choi, H.J., C.F. Ebersbacher, F.S. Quan, and C.D. Montemagno. 2013c. pH stability and comparative evaluation of ranaspumin-2 foam for application in biochemical reactors. Nanotechnology 24: 055603.PubMedCrossRefGoogle Scholar
  7. Choi, H.J., D.G. Yoo, B.J. Bondy, F.S. Quan, R.W. Compans, S.M. Kang, and M.R. Prausnitz. 2012b. Stability of influenza vaccine coated onto microneedles. Biomaterials 33: 3756–3769.PubMedCentralPubMedCrossRefGoogle Scholar
  8. Farag-Mahmod, F.I., P.R. Wyde, J.P. Rosborough, and H.R. Six. 1988. Immunogenicity and efficacy of orally administered inactivated influenza virus vaccine in mice. Vaccine 6: 262–268.PubMedCrossRefGoogle Scholar
  9. Fiore, A.E., T.M. Uyeki, K. Broder, L. Finelli, G.L. Euler, J.A. Singleton, J.K. Iskander, P.M. Wortley, D.K. Shay, J.S. Bresee, and N.J. Cox. 2010. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recommendations and Reports 59: 1–62.Google Scholar
  10. Giudice, E.L., and J.D. Campbell. 2006. Needle-free vaccine delivery. Advanced Drug Delivery Reviews 58: 68–89.PubMedCrossRefGoogle Scholar
  11. Harper, S.A., K. Fukuda, T.M. Uyeki, N.J. Cox, and C.B. Bridges. 2004. Prevention and control of influenza: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recommendations and Reports 53: 1–40.Google Scholar
  12. Hirst, G.K. 1942. The quantitative determination of influenza virus and antibodies by means of red cell agglutination. Journal of Experimental Medicine 75: 49–64.PubMedCentralPubMedCrossRefGoogle Scholar
  13. Hunt, J.N. 1959. Gastric emptying and secretion in man. Physiological Reviews 39: 491–533.PubMedGoogle Scholar
  14. Lazzell, V., R.H. Waldman, C. Rose, R. Khakoo, A. Jacknowitz, and S. Howard. 1984. Immunization against influenza in humans using an oral enteric-coated killed virus-vaccine. Journal of Biological Standardization 12: 315–321.PubMedCrossRefGoogle Scholar
  15. Le Maire, M., P. Champeil, and J.V. Moller. 2000. Interaction of membrane proteins and lipids with solubilizing detergents. Biochimica et Biophysica Acta 1508: 86–111.PubMedCrossRefGoogle Scholar
  16. Lee, I.-S., H.J. Kim, D.H. Lee, G.B. Hwang, J.H. Jung, M. Lee, J. Lim, and B.U. Lee. 2011. Aerosol particle size distribution and genetic characteristics of aerosolized influenza A H1N1 virus vaccine particles. Aerosol Air Qual Res 11: 230–237.Google Scholar
  17. Luykx, D.M., M.G. Casteleijn, W. Jiskoot, J. Westdijk, and P.M. Jongen. 2004. Physicochemical studies on the stability of influenza haemagglutinin in vaccine bulk material. European Journal of Pharmaceutical Sciences 23: 65–75.PubMedCrossRefGoogle Scholar
  18. Mutsch, M., W. Zhou, P. Rhodes, M. Bopp, R.T. Chen, T. Linder, C. Spyr, and R. Steffen. 2004. Use of the inactivated intranasal influenza vaccine and the risk of Bell’s palsy in Switzerland. New England Journal of Medicine 350: 896–903.PubMedCrossRefGoogle Scholar
  19. Neutra, M.R., and P.A. Kozlowski. 2006. Mucosal vaccines: the promise and the challenge. Nature Reviews Immunology 6: 148–158.PubMedCrossRefGoogle Scholar
  20. Ollivon, M., S. Lesieur, C. Grabielle-Madelmont, and M. Paternostre. 2000. Vesicle reconstitution from lipid-detergent mixed micelles. Biochimica et Biophysica Acta 1508: 34–50.PubMedCrossRefGoogle Scholar
  21. Palese, P. 2006. Making better influenza virus vaccines? Emerging Infectious Diseases 12: 61–65.PubMedCentralPubMedCrossRefGoogle Scholar
  22. Quan, F.S., R.W. Compans, H.H. Nguyen, and S.M. Kang. 2008. Induction of heterosubtypic immunity to influenza virus by intranasal immunization. Journal of Virology 82: 1350–1359.PubMedCentralPubMedCrossRefGoogle Scholar
  23. Quan, F.S., Z.N. Li, M.C. Kim, D. Yang, R.W. Compans, D.A. Steinhauer, and S.M. Kang. 2011. Immunogenicity of low-pH treated whole viral influenza vaccine. Virology 417: 196–202.PubMedCentralPubMedCrossRefGoogle Scholar
  24. Skehel, J.J., P.M. Bayley, E.B. Brown, S.R. Martin, M.D. Waterfield, J.M. White, I.A. Wilson, and D.C. Wiley. 1982. Changes in the conformation of influenza-virus hemagglutinin at the pH optimum of virus-mediated membrane-fusion. Proceedings of the National Academy of Sciences USA 79: 968–972.CrossRefGoogle Scholar
  25. Staneková, Z., and E. Vareckova. 2010. Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine development. Virology Journal 7: 351.PubMedCentralPubMedCrossRefGoogle Scholar
  26. Sun, S.T., A. Milon, T. Tanaka, G. Ourisson, and Y. Nakatani. 1986. Osmotic swelling of unilamellar vesicles by the stopped-flow light-scattering method-elastic properties of vesicles. Biochimica et Biophysica Acta 860: 525–530.CrossRefGoogle Scholar
  27. Szarka, L.A., and M. Camilleri. 2009. Methods for measurement of gastric motility. American Journal of Physiology Gastrointestinal and Liver Physiology 296: G461–G475.PubMedCrossRefGoogle Scholar
  28. Teale, F.W., and G. Weber. 1957. Ultraviolet fluorescence of the aromatic amino acids. Biochemical Journal 65: 476–482.PubMedCentralPubMedGoogle Scholar
  29. Thompson, W.W., D.K. Shay, E. Weintraub, L. Brammer, N. Cox, L.J. Anderson, and K. Fukuda. 2003. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289: 179–186.PubMedCrossRefGoogle Scholar
  30. Wiley, D.C., and J.J. Skehel. 1987. The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annual Review of Biochemistry 56: 365–394.PubMedCrossRefGoogle Scholar

Copyright information

© The Pharmaceutical Society of Korea 2013

Authors and Affiliations

  1. 1.Nanotechnology Accelerator and Department of Chemical and Materials Engineering, National Institute for NanotechnologyUniversity of AlbertaEdmontonCanada
  2. 2.Animal and Plant Quarantine AgencyAnyangKorea
  3. 3.Center for Inflammation, Immunity and Infection and Department of BiologyGeorgia State UniversityAtlantaUSA

Personalised recommendations